The PEX19 gene encodes the peroxisomal farnesylated protein, which is necessary for early peroxisomal biogenesis . The gene is located on chromosome 1 and produces multiple transcript variants through alternative splicing . The protein itself acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs) .
PEX19 is essential for the assembly of functional peroxisomes. It binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains . PEX19 then targets these PMPs to the peroxisome membrane by binding to the integral membrane protein PEX3 . This process ensures that peroxisomes are properly formed and maintained, allowing them to carry out their metabolic functions effectively .
Mutations in the PEX19 gene can lead to peroxisome biogenesis disorders (PBDs), which are a group of genetically heterogeneous, autosomal recessive diseases characterized by multiple defects in peroxisome function . One such disorder is Zellweger syndrome (ZWS), a severe condition that affects the development of the brain, liver, and kidneys . Patients with PBDs exhibit defects in the import of one or more classes of peroxisomal matrix proteins into the organelle .
Recombinant PEX19 is produced using various expression systems, such as E. coli, to study its function and role in peroxisomal biogenesis . The recombinant protein is often tagged with His-ABP for purification purposes and is used in various research applications, including blocking assays and protein interaction studies .